Emerging evidence for platelets as immune and inflammatory effector cells

Frontiers in Immunology

Volumn 5, Issue DEC, 2014, Pages

  Rondina, Matthew T ^a,b   Garraud, Olivier ^c,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITÉ LYON 1   (France)

^d French Blood Center   (France)

Author keywords

Immunity; Infection; Pathoge; Platelets; Sepsis

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOTACTIC FACTOR; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN VI; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; SERINE PROTEINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

BLOOD VESSEL PERMEABILITY; CELL ACTIVATION; CELL INTERACTION; COMPLEMENT ACTIVATION; DENGUE; ENDOTHELIUM CELL; HEMOSTASIS; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; MALARIA; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; REVIEW; SEPSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA;

EID: 84919473073     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00653     Document Type: Review

References (54)

1. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res (2013) 112(11):1506-19. doi:10.1161/CIRCRESAHA.113.300512
2. Vieira-de-Abreu A, Rondina MT, Weyrich AS, Zimmerman GA. Inflammation. 3rd ed. In: Michelson AD, editor. Platelets. New York, NY: Elsevier (2012). p. 733-66.
3. Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood (2014) 123(18):2759-67. doi:10.1182/blood-2013-11-462432
4. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11(4):264-74. doi:10.1038/nri2956
5. Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F. Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res (2011) 127(4):283-6. doi:10.1016/j.thromres.2010.10.015
6. Kasirer-Friede A, Kahn ML, Shattil SJ. Platelet integrins and immunoreceptors. Immunol Rev (2007) 218:247-64. doi:10.1111/j.1600-065X.2007.00532.x
7. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 327(5965):580-3. doi:10.1126/science.1181928
8. Zahn A, Jennings N, Ouwehand WH, Allain JP. Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol (2006) 87(Pt 8):2243-51. doi:10.1099/vir.0.81826-0
9. Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, et al. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk. Arterioscler Thromb Vasc Biol (2007) 27(2):422-9. doi:10.1161/01.ATV.0000252826.96134.21
10. Chaipan C, Soilleux EJ, Simpson P, Hofmann H, Gramberg T, Marzi A, et al. DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets. J Virol (2006) 80(18):8951-60. doi:10.1128/JVI.00136-06
11. Hottz ED, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, et al. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost (2013) 11(5):951-62. doi:10.1111/jth.12178
12. Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci (2010) 67(4):499-511. doi:10.1007/s00018-009-0205-1
13. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional toll-like receptor-4. Blood (2005) 106(7):2417-23. doi:10.1182/blood-2005-03-0916
14. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol Cell Biol (2005) 83(2):196-8. doi:10.1111/j.1440-1711.2005.01314.x
15. Koupenova M, Vitseva O, MacKay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood (2014) 124(5):791-802. doi:10.1182/blood-2013-11-536003
16. Garraud O, Cognasse F. Platelet toll-like receptor expression: the link between "danger" ligands and inflammation. Inflamm Allergy Drug Targets (2010) 9(5):322-33. doi:10.2174/187152810793937991
17. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science (2010) 327(5963):291-5. doi:10.1126/science.1183021
18. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 464(7285):104-7. doi:10.1038/nature08780
19. Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2012) 34(1):5-30. doi:10.1007/s00281-011-0286-4
20. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost (2005) 94(4):831-8.
21. Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol (2008) 181(5):3495-502. doi:10.4049/jimmunol.181.5.3495
22. Rondina MT, Schwertz H, Harris ES, Kraemer BF, Campbell RA, Mackman N, et al. The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 9(4):748-58. doi:10.1111/j.1538-7836.2011.04208.x
23. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13(4):463-9. doi:10.1038/nm1565
24. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4(7):499-511. doi:10.1038/nri1391
25. Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol (2012) 198(4):561-74. doi:10.1083/jcb.201111136
26. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood (2006) 107(2):637-41. doi:10.1182/blood-2005-06-2202
27. Panigrahi S, Ma Y, Hong L, Gao D, West XZ, Salomon RG, et al. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Circ Res (2013) 112(1):103-12. doi:10.1161/CIRCRESAHA.112.274241
28. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 122(3):379-91. doi:10.1016/j.cell.2005.06.015
29. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 154(3):485-90. doi:10.1083/jcb.200105058
30. Lamkanfi M, Dixit VM. Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol (2011) 187(2):597-602. doi:10.4049/jimmunol.1100229
31. Stutz A, Golenbock DT, Latz E. Inflammasomes: too big to miss. J Clin Invest (2009) 119(12):3502-11. doi:10.1172/JCI40599
32. Cloutier N, Pare A, Farndale RW, Schumacher HR, Nigrovic PA, Lacroix S, et al. Platelets can enhance vascular permeability. Blood (2012) 120(6):1334-43. doi:10.1182/blood-2012-02-413047
33. Brown GT, Narayanan P, Li W, Silverstein RL, McIntyre TM. Lipopolysaccharide stimulates platelets through an IL-1beta autocrine loop. J Immunol (2013) 191(10):5196-203. doi:10.4049/jimmunol.1300354
34. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 122(20), 3405-14. doi:10.1182/blood-2013-05-504449
35. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood (2008) 111(10):5028-36. doi:10.1182/blood-2007-06-097410
36. Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol (2005) 238(1):1-9. doi:10.1016/j.cellimm.2005.12.005
37. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 100(1):27-40. doi:10.1161/01.RES.0000252802.25497.b7
38. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med (1995) 1(9):932-7. doi:10.1038/nm0995-932
39. Speth C, Hagleitner M, Ott HW, Wurzner R, Lass-Florl C, Rambach G. Aspergillus fumigatus activates thrombocytes by secretion of soluble compounds. J Infect Dis (2013) 207(5):823-33. doi:10.1093/infdis/jis743
40. Speth C, Rambach G, Lass-Florl C. Platelet immunology in fungal infections. Thromb Haemost (2014) 112(4):632-9. doi:10.1160/TH14-01-0074
41. Hottz ED, Tolley ND, Zimmerman GA, Weyrich AS, Bozza FA. Platelets in dengue infection. Drug Discov Today Dis Mech (2011) 8:e33-8. doi:10.1016/j.ddmec.2011.09.001
42. Katz JN, Kolappa KP, Becker RC. Beyond thrombosis: the versatile platelet in critical illness. Chest (2011) 139(3):658-68. doi:10.1378/chest.10-1971
43. Schwertz H, Weyrich AS, Zimmerman GA. Cellular interactions of platelets, leukocytes and endothelium in systemic inflammatory responses and sepsis. In: Castro Faria Neto H, Marcus D, editors. Sepsis: From Bench to Bedside. Rio de Janerio: Revinter Press (2007). p. 107-20.
44. Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, et al. Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res (2011) 129(6):729-35. doi:10.1016/j.thromres.2011.11.031
45. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med (1997) 23(4):379-85. doi:10.1007/s001340050344
46. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis (2008) 8:86. doi:10.1186/1471-2334-8-86
47. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol (2006) 87(Pt 12):3623-30. doi:10.1099/vir.0.82093-0
48. Greenbaum DC, FitzGerald GA. Platelets, pyrexia, and plasmodia. N Engl J Med (2009) 361(5):526-8. doi:10.1056/NEJMcibr0903050
49. Peyron F, Polack B, Lamotte D, Kolodie L, Ambroise-Thomas P. Plasmodium falciparum growth inhibition by human platelets in vitro. Parasitology (1989) 99(Pt 3):317-22. doi:10.1017/S0031182000059011
50. McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK, et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science (2009) 323(5915):797-800. doi:10.1126/science.1166296
51. Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe (2008) 4(2):179-87. doi:10.1016/j.chom.2008.07.003
52. Coelho HC, Lopes SC, Pimentel JP, Nogueira PA, Costa FT, Siqueira AM, et al. Thrombocytopenia in Plasmodium vivax malaria is related to platelets phagocytosis. PLoS One (2013) 8(5):e63410. doi:10.1371/journal.pone.0063410
53. van der Heyde HC, Gramaglia I, Sun G, Woods C. Platelet depletion by anti-CD41 (alphaIIb) mAb injection early but not late in the course of disease protects against Plasmodium berghei pathogenesis by altering the levels of pathogenic cytokines. Blood (2005) 105(5):1956-63. doi:10.1182/blood-2004-06-2206
54. Essien EM, Ebhota MI. Platelet secretory activities in acute malaria (Plasmodium falciparum) infection. Acta Haematol (1983) 70(3):183-8. doi:10.1159/000206720